Latest by Kenyon Farrow
Georgia’s Living Bridge Center has found ways to engage rural people living with HIV and retain them in care.
“[The study] shows that the incidence of HIV in this cohort is zero averting 85 new infections," said Jean-Michel Molina, M.D., Ph.D., the lead researcher of the Prévenir study.
Results from the PARTNER2 study, presented by Alison Rodger at AIDS 2018, yielded an equivalent level of confidence for gay men as it had for heterosexual couples in the original PARTNER study several years ago.
Providers and researchers at the Adherence 2018 Conference discussed the role of data and surveillance through several approaches and how they are being used to understand local and global epidemics, marshal resources, and mobilize stakeholders for i...
A home-based HIV test with an app that connects people to care helps people find out their status and not disappear due to shame and self-stigma.
Is Ending the HIV Epidemic Possible, and If So, How? IAPAC Meeting in Geneva Takes Stock of Progress and the Road Ahead
More than 200 health care providers, researchers, and advocates gathered in Geneva, Switzerland, from across the globe to discuss progress and challenges in turning the tide on the HIV epidemic across the globe at the "Controlling the Epidemic" Summi...
The CDC has released new data at the Conference on Retroviruses and Opportunistic Infections (CROI) estimating that only a small percentage of people most at risk for HIV infection have actually been prescribed pre-exposure prophylaxis (PrEP).
The lack of Medicaid expansion in the South is creating worse racial disparities in the U.S., according to researchers and medical providers discussing the HIV care cascade at CROI 2018.
It's strange to think about the Conference on Retroviruses and Opportunistic Infections (CROI) being the hottest ticket in town. But for the research community, CROI is in fact one of the more significant annual conferences on the latest HIV research...
A recently published study shows positive early results for a once-weekly HIV antiretroviral in pill form that slowly releases the medications, but many more steps are needed to prove it can work in humans.